Literature DB >> 31515751

A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome.

Elsa Meireles1, Filipe Machado2, Luís Teles2, Anna Chumakova3, Joana Sequeira2, Ana Spínola3.   

Abstract

Association of acquired factor II deficiency and lupus anticoagulant is a rare disease that can be related to sudden, severe or fatal haemorrhage. We present a 74-years-old woman with history of myelodysplastic syndrome, admitted to the Emergency Department due to spontaneous mucocutaneous bleeding. Coagulation assays revealed prolonged prothrombin time and activated partial thromboplastin time with evidence of an immediate acting inhibitor. Antithrombotic therapy usage, drug ingestion, disseminated intravascular coagulation, liver dysfunction and sepsis were excluded. Patient was admitted for close monitoring and etiological evaluation. A comprehensive bleeding diathesis workup was performed showing factor II levels severely decreased and transient positive lupus anticoagulant. Immunosuppression with methylprednisolone lasted for 3 days, followed by prednisolone. After 20 days she was discharged and follow-up was scheduled. Early diagnosis of lupus anticoagulant hypoprothrombinemia syndrome is critical, as it may result in fatal complications if not treated appropriately. There is no consensus regarding the best treatment, most being based on immunosuppression.

Entities:  

Keywords:  Coagulation factor II; Corticosteroids; Hemorrhagic disorders; Hypoprothrombinemia; Lupus anticoagulant

Year:  2020        PMID: 31515751     DOI: 10.1007/s11239-019-01955-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

Review 1.  Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.

Authors:  S M N Mulliez; F De Keyser; C Verbist; A Vantilborgh; W Wijns; I Beukinga; K M J Devreese
Journal:  Lupus       Date:  2014-11-12       Impact factor: 2.911

2.  A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity.

Authors:  S I RAPAPORT; S B AMES; B J DUVALL
Journal:  Blood       Date:  1960-02       Impact factor: 22.113

Review 3.  Autoantibodies to coagulation factors and bleeding disorders.

Authors:  A E Ahmed
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  Acquired antiprothrombin antibodies: an unusual cause of bleeding.

Authors:  Cristiana Carvalho; Carolina Viveiro; Paulo Maia; Teresa Rezende
Journal:  BMJ Case Rep       Date:  2013-01-07

Review 5.  Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature.

Authors:  Karin Mazodier; Laurent Arnaud; Alexis Mathian; Nathalie Costedoat-Chalumeau; Julien Haroche; Camille Frances; Jean-Robert Harlé; Gilles Pernod; Eric Lespessailles; Philippe Gaudin; Hilaire Charlanne; Eric Hachulla; Patrick Niaudet; Jean-Charles Piette; Zahir Amoura
Journal:  Medicine (Baltimore)       Date:  2012-09       Impact factor: 1.889

Review 6.  Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature.

Authors:  R D Paschal; A T Neff
Journal:  Haemophilia       Date:  2012-09-19       Impact factor: 4.287

7.  A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome.

Authors:  S P Bajaj; S I Rapaport; D S Fierer; K D Herbst; D B Schwartz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

8.  Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.

Authors:  Rakesh Kumar Pilania; Deepti Suri; Ankur Kumar Jindal; Narender Kumar; Avinash Sharma; Praveen Sharma; Sandesh Guleria; Amit Rawat; Jasmina Ahluwalia; Surjit Singh
Journal:  Rheumatol Int       Date:  2018-08-11       Impact factor: 3.580

  8 in total
  1 in total

1.  [Recurrent epistaxis with coagulation disorders in a boy aged 2 years].

Authors:  Jia-Zhuo Li; Xin Tian; Chu-Shu Liao; Xiang-Ling He; Cheng-Guang Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.